Sonoma Pharmaceuticals, Inc.
(NASDAQ : OCLS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.21%165.170.7%$1346.72m
LLYEli Lilly & Co. 1.06%324.961.1%$1079.02m
ABBVAbbVie, Inc. 1.87%140.901.9%$868.16m
PFEPfizer Inc. 1.11%44.630.9%$807.02m
BMYBristol-Myers Squibb Co. 1.28%71.441.0%$782.64m
MRKMerck & Co., Inc. 0.67%88.140.7%$715.16m
AZNAstraZeneca Plc 1.94%56.631.0%$395.03m
ALNYAlnylam Pharmaceuticals, Inc. -0.25%196.308.2%$216.85m
GSKGSK Plc 2.12%30.890.3%$214.09m
NVSNovartis AG 1.80%78.050.2%$205.29m
GBTGlobal Blood Therapeutics, Inc. -0.01%68.485.4%$191.16m
IDXXIDEXX Laboratories, Inc. 3.04%346.913.9%$189.88m
HZNPHorizon Therapeutics Plc 1.54%65.255.4%$176.32m
ATXIAvenue Therapeutics, Inc. 22.24%14.070.0%$170.29m
SRPTSarepta Therapeutics, Inc. 0.36%110.3412.4%$137.23m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in developing and producing Stabilized Hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care and dermatological conditions. Its products educe infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Woodstock, GA.